Clinical Trial
2020 Nov 11.
JOURNAL：Circulation.
Article Link
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
SD Anker, J Butler, EMPEROR-Reduced Trial Committees and Investigators et al.
KEYWORDS
cardiorenal outcomes; empagliflozin
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
